Published: 27 August 2016
Author(s): Laurent Fauchier, Juan M. Ruiz-Nodar, Mariano Valdés, Denis Angoulvant, Gregory Y.H. Lip, Francisco Marín
Issue: August 2016
Section: Letter to the Editor

Thromboprophylaxis for patients with coronary artery disease and atrial fibrillation (AF) is problematic when there is a low or moderate risk of stroke (CHADS2 score=0 or 1), particularly when patients experience an acute coronary syndrome or undergo intracoronary stent implantation. Some physicians may be reluctant to prescribe oral anticoagulation (OAC) in these patients and several recent guidelines propose slightly different management in such settings [1,2]. Our goal was to evaluate whether treatment with an OAC is appreciably beneficial in these AF patients.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.